EP0857020A4 - Formulation de secretagogue stimulant la secretion de l'hormone de croissance, destinee a etre granulee par voie humide - Google Patents
Formulation de secretagogue stimulant la secretion de l'hormone de croissance, destinee a etre granulee par voie humideInfo
- Publication number
- EP0857020A4 EP0857020A4 EP96937761A EP96937761A EP0857020A4 EP 0857020 A4 EP0857020 A4 EP 0857020A4 EP 96937761 A EP96937761 A EP 96937761A EP 96937761 A EP96937761 A EP 96937761A EP 0857020 A4 EP0857020 A4 EP 0857020A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- growth hormone
- wet granulation
- hormone secretagogue
- granulation formulation
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US589795P | 1995-10-27 | 1995-10-27 | |
US590195P | 1995-10-27 | 1995-10-27 | |
US5897P | 1995-10-27 | ||
US5901P | 1995-10-27 | ||
GBGB9603238.8A GB9603238D0 (en) | 1996-02-16 | 1996-02-16 | Wet granulation formulation of a growth hormone secretagogue |
GB9603238 | 1996-02-16 | ||
GBGB9603834.4A GB9603834D0 (en) | 1996-02-23 | 1996-02-23 | Amorphous form of a growth hormone secretagogue |
GB9603834 | 1996-02-23 | ||
PCT/US1996/017196 WO1997015191A1 (fr) | 1995-10-27 | 1996-10-23 | Formulation de secretagogue stimulant la secretion de l'hormone de croissance, destinee a etre granulee par voie humide |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0857020A1 EP0857020A1 (fr) | 1998-08-12 |
EP0857020A4 true EP0857020A4 (fr) | 1999-01-07 |
Family
ID=27451404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96937761A Withdrawn EP0857020A4 (fr) | 1995-10-27 | 1996-10-23 | Formulation de secretagogue stimulant la secretion de l'hormone de croissance, destinee a etre granulee par voie humide |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0857020A4 (fr) |
JP (1) | JPH11513989A (fr) |
AU (1) | AU7522896A (fr) |
CA (1) | CA2234817A1 (fr) |
WO (1) | WO1997015191A1 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1930021A3 (fr) | 1999-02-18 | 2008-06-18 | Kaken Pharmaceutical Co., Ltd. | Nouveaux dérivés d'amide en tant que secrétagogues d'hormone de croissance |
ATE309358T1 (de) * | 1999-07-26 | 2005-11-15 | Baylor College Medicine | Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein |
ATE290040T1 (de) * | 1999-11-12 | 2005-03-15 | Scherer Technologies Inc R P | Dämpfgranulate aus mikrokristalliner cellulose |
BR0113626A (pt) * | 2000-08-30 | 2003-06-17 | Pfizer Prod Inc | Formulações de liberação sustentada para secretores de hormÈnio do crescimento |
EP1377276B1 (fr) * | 2001-04-10 | 2011-10-05 | Sun Pharma Advanced Research Company Limited | Composition a liberation par impulsion reglee dans le temps |
PT1596870E (pt) † | 2002-12-20 | 2007-10-15 | Hoffmann La Roche | Formulação com uma dose elevada de ibandronato |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
UY29527A1 (es) * | 2005-05-13 | 2006-12-29 | Schering Ag | Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato. |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
EP2644618B1 (fr) | 2007-02-09 | 2016-08-17 | Ocera Therapeutics, Inc. | Intermédaires dans la synthese de modulateurs macrocycliques du récepteur de la ghréline |
WO2010092828A1 (fr) * | 2009-02-12 | 2010-08-19 | 富士化学工業株式会社 | Composition de particule se désintégrant et matériau moulé par compression se désintégrant rapidement comprenant celle-ci |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
WO2017075535A1 (fr) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Méthodes de traitement de troubles neurodégénératifs |
WO2024096892A1 (fr) | 2022-11-03 | 2024-05-10 | Lumos Pharma, Inc. | Formulations orales compactables d'ibutamoren |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011029A1 (fr) * | 1993-10-19 | 1995-04-27 | Merck & Co., Inc. | Combinaison de biphosphonates et de secretagogues de l'hormone de croissance |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5536716A (en) * | 1992-12-11 | 1996-07-16 | Merck & Co., Inc. | Spiro piperidines and homologs which promote release of growth hormone |
-
1996
- 1996-10-23 JP JP9516841A patent/JPH11513989A/ja active Pending
- 1996-10-23 AU AU75228/96A patent/AU7522896A/en not_active Abandoned
- 1996-10-23 WO PCT/US1996/017196 patent/WO1997015191A1/fr not_active Application Discontinuation
- 1996-10-23 CA CA 2234817 patent/CA2234817A1/fr not_active Abandoned
- 1996-10-23 EP EP96937761A patent/EP0857020A4/fr not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011029A1 (fr) * | 1993-10-19 | 1995-04-27 | Merck & Co., Inc. | Combinaison de biphosphonates et de secretagogues de l'hormone de croissance |
Non-Patent Citations (1)
Title |
---|
See also references of WO9715191A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1997015191A1 (fr) | 1997-05-01 |
EP0857020A1 (fr) | 1998-08-12 |
AU7522896A (en) | 1997-05-15 |
JPH11513989A (ja) | 1999-11-30 |
CA2234817A1 (fr) | 1997-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69637063D1 (de) | Oral verfügbare wachstumshormon-sekretagoge | |
PL321590A1 (en) | Compounds capable to cause liberation of the growth hormone | |
HUP9901718A3 (en) | Analogs of parathyroid hormone | |
EP0845265A4 (fr) | Preparation pour muqueuses a base de peptides a activite physiologique | |
IL116743A0 (en) | Pharmaceutical composition comprising a growth hormone | |
ZA968989B (en) | Polymorphic forms of a growth hormone secretagogue | |
HUP0002664A3 (en) | Tartrate salt of a substituted dipeptide as growth hormone secretagogue | |
HUP9900301A3 (en) | Hormone patch | |
IL127770A0 (en) | Aqueous formulations of peptides | |
EP0669830A4 (fr) | Analogues dipeptidiques substitues favorisant la liberation de l'hormone de croissance. | |
ZA937222B (en) | Benzo-fused lactams promote release of growth hormone | |
ZA945463B (en) | Benzo-fused lactams promote release of growth hormone | |
ZA945462B (en) | Benzo-fused lactams promote release of growth hormone | |
EP0857020A4 (fr) | Formulation de secretagogue stimulant la secretion de l'hormone de croissance, destinee a etre granulee par voie humide | |
ZA949899B (en) | Heterocyclic-fused lactams promote release of growth hormone | |
PL338883A1 (en) | Growth hormone secretion stimulating compounds | |
IL154115A0 (en) | Process for the preparation of growth hormone secretagogues | |
HUP9902095A3 (en) | New process for the preparation of a growth hormone secretagogue | |
ZA936692B (en) | Physiologically active peptide composition | |
EP0702958A4 (fr) | Preparation vaginale contenant un peptide a activite physiologique | |
GB9602414D0 (en) | Camphor compounds promote release of growth hormone | |
AU4993497A (en) | Convergent process for the preparation of a growth hormone secretagogue | |
GB9823422D0 (en) | Naptho-fused lactams promate release of growth hormone | |
IL116742A0 (en) | Pharmaceutical composition comprising a growth hormone | |
GB9603238D0 (en) | Wet granulation formulation of a growth hormone secretagogue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980527 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19981125 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20020319 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020730 |